Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Want to Invest in the S&P 500? This ETF Is a Smart Choice With Uncertainty Surrounding the Stock Market and Economy.fool.com
Via The Motley Fool · April 17, 2025
2 Stocks Down by 25% or More This Year to Buy and Holdfool.com
Via The Motley Fool · April 17, 2025
Where Will Amazon Stock Be in 5 Years?fool.com
Via The Motley Fool · April 17, 2025
5 Dividend Aristocrats® So Good You'll Never Want to Sellfool.com
Turn $180 into $7M? These 5 Dividend Aristocrats show how it's possible.
Via The Motley Fool · April 17, 2025
Is This the Perfect Age to Start Collecting Social Security?fool.com
Via The Motley Fool · April 17, 2025
3 Reasons to Buy Archer Aviation Stock Like There's No Tomorrowfool.com
Via The Motley Fool · April 17, 2025
Supercharge Your Passive Income. Every $1,000 Invested in This Top High-Yield Dividend Stock Can Produce $75 in Income Each Year.fool.com
Via The Motley Fool · April 17, 2025
Renault Chairman To Step Down From Nissan’s Board: Retail’s Disappointedstocktwits.com
Jean-Dominique Senard was Nissan’s vice chairman and will step down at the end of the annual general meeting of shareholders scheduled for June, the Japanese automaker said.
Via Stocktwits · April 17, 2025
AUD/USD Forecast: Markets Eye RBA Cut Despite Solid Jobs Datatalkmarkets.com
The AUD/USD forecast shows a resilient labor market in Australia.
Via Talk Markets · April 17, 2025
Is SCHLUMBERGER LTD (NYSE:SLB) the type of stock Peter Lynch would love?chartmill.com
With a strategy that emphasized steady earnings growth and a strong market position, Peter Lynch sought out long-term winners. We put SCHLUMBERGER LTD (NYSE:SLB) to the test against his stock-picking rules.
Via Chartmill · April 17, 2025
XRP Is Missing 1 Big Thing Other Blockchains Have. Here's Why That's Good Newsfool.com
Via The Motley Fool · April 17, 2025
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.investors.com
A revolution in oncology could help cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.
Via Investor's Business Daily · April 17, 2025
3 Reasons to Buy Rivian Stock Like There's No Tomorrowfool.com
Via The Motley Fool · April 17, 2025
Market Analysis - Thursday, April 17talkmarkets.com
This morning’s SPX futures rose to 5341.86, above the Cycle Bottom where it had closed yesterday.
Via Talk Markets · April 17, 2025
Is DONNELLEY FINANCIAL SOLUTION (NYSE:DFIN) the type of stock Peter Lynch would love?chartmill.com
Peter Lynch’s approach focused on identifying undervalued growth stocks with simple, scalable businesses. We examine whether DONNELLEY FINANCIAL SOLUTION (NYSE:DFIN) fits the characteristics of a Lynch-approved investment.
Via Chartmill · April 17, 2025
Is Bitcoin a Hedge Against Market Volatility? This Chart Suggests Otherwise.fool.com
Via The Motley Fool · April 17, 2025
3 of Wall Street’s Favorite Stocks That Concern Us
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Via StockStory · April 17, 2025
1 S&P 500 Stock for Long-Term Investors and 2 to Turn Down
While the S&P 500 includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Via StockStory · April 17, 2025
3 of Wall Street’s Favorite Stocks Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Via StockStory · April 17, 2025
2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 to Be Wary Of
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · April 17, 2025
3 of Wall Street’s Favorite Stocks Showing Warning Signs
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · April 17, 2025
Is Apple Stock a Buy Now?fool.com
Via The Motley Fool · April 17, 2025
Trump Wants 90 Trade Deals In 90 Days. How Realistic Is That?talkmarkets.com
The administration says we are on “Trump time”. Any bets?
Via Talk Markets · April 17, 2025
Exploring high growth characteristics of BRINKER INTERNATIONAL INC (NYSE:EAT).chartmill.com
BRINKER INTERNATIONAL INC (NYSE:EAT) is a candidate for high growth investors. Here's why. Full fundamental and technical analysis of (NYSE:EAT).
Via Chartmill · April 17, 2025
2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Foreverfool.com
Via The Motley Fool · April 17, 2025